NHF
----------------
ASX:NHF (nib holdings) has sustained strong revenue growth over the last five years but has grappled with volatile operating margins and earnings fluctuations. Revenue climbed from about A$2.6 billion to A$3.7 billion, while Net Profit After Tax (NPAT) and Return on Equity (ROE) have generally remained healthy, though heavily reliant on underlying market conditions. [1, 2, 3]
5-Year Financial Summary
- Profit & Revenue: Top-line growth has been consistent, pushing group revenue to A$3.73 billion. However, net income has experienced volatility due to fluctuations in claims inflation and underwriting margins. For instance, recent results showed NPAT fluctuating, dropping from FY24 to FY25, before flattening out in the most recent half-year results. [1, 2, 3, 4, 5]
- Debt & Leverage: The balance sheet has remained robust. NIB holds moderate debt, with a debt-to-equity ratio of approximately 22%. The company boasts healthy liquidity and a strong interest coverage ratio. [1, 2]
- https://stockanalysis.com/quote/asx/nhf/financials/ratios/
- Recent D/E ratios:
- 2026 - 0.25; 2025 - 0.28; 2024 - 0.29; 2023 - 0.29
Strategic Updates & Outlook
- Productivity: NIB has successfully tackled increasing claims costs and expenses by focusing on digital-first strategies, process automation, and a strategic pivot to pure-play health insurance (highlighted by the recent sale of its travel insurance arm). [1, 2]
- Dividends: The company has maintained its reputation for reliable shareholder distributions, continuing to offer fully franked dividends (3.89% in 2026) with a historical payout ratio often ranging between 60% and 70%. Dividend growth ave 7.41 %
- https://stockanalysis.com/quote/asx/NHF/dividend/
.................
As of July 2026, the 10-year mean historical Price-to-Earnings (P/E) ratio for nib holdings limited (ASX: NHF) sits at 21.04, with its current trailing 12-month (TTM) P/E ratio trading lower at approximately 17.99. [1]
The stock's valuation has cooled down from the elevated levels seen between 2021 and 2023, which were driven by fluctuating post-pandemic insurance claims and premium adjustments. [1, 2]
Interactive price chart for NIB Holdings Limited (ASX: NHF) showing long term market trends alongside its current 17.99 P/E ratio.
Annual P/E Ratio Breakdown (Past 10 Years)
Historical financial data from platforms like Companies Market Cap and Market Index highlights the year-end P/E ratios for NHF: [1, 2, 3]
| Year | P/E Ratio | Valuation Context |
|---|---|---|
| 2025 | 17.80 | Stabilized underlying operating profit; tracking closer to historical baseline. |
| 2024 | 18.70 | Steady earnings growth offsets policy management costs. |
| 2023 | 20.10 | Rebound in post-lockdown medical procedures slightly compresses multiple. |
| 2022 | 22.30 | Spiked over 56% due to high pandemic-induced premium retention and deferred claims. |
| 2021 | 24.94 | Higher range peak as risk margins temporarily expanded during initial Covid rollouts. |
| 2020 | 35.70 | Extreme cyclical high caused by sharp, temporary net profit compression at the pandemic's onset. |
| 2019 | 19.20 | Moderate, consistent private health sector growth. |
| 2018 | 17.23 | Broadly aligned with the historical Australian specialty insurance sector average. |
| 2017 | 17.45 | Stable operating expense margins and steady policyholder additions. |
| 2016 | 18.46 | Underpins long-term trend lines preceding subsequent macro volatility cycles. |
Track Key Financial Indicators
- Sector Benchmarking: At ~18.0x, NHF trades roughly in line with the broader ASX specialty insurance sector average (~18.4x), signaling a fair relative valuation compared to core market peers like Medibank. [1, 2]
- Growth Outlook: According to consensus expectations reported on Simply Wall St, NHF's EPS is forecasted to expand over the coming three years, providing solid earnings cover for its current ~4% dividend yield
..................
ROIC vs WACC
For nib holdings limited (ASX: NHF), the return on invested capital (ROIC) consistently outpaces its weighted average cost of capital (WACC), maintaining a positive economic spread over the past 10 years. Current metrics show an ROIC of approximately 10.75% to 14.99% against a WACC of roughly 4.35%. [1, 2, 3]
Capital Returns and Value Creation
..............
Buffet style analysis - ARGO vs NIB
An analysis of Argo Investments (ASX: ARG) and NIB Holdings (ASX: NHF) using Warren Buffett’s principles of economic moats, capital allocation, and valuation reveals key distinctions.
| Metric | Argo Investments (ASX: ARG) | NIB Holdings (ASX: NHF) |
|---|---|---|
| Business Model | Listed Investment Company (LIC) | Private Health Insurer |
| Current P/E Ratio | 26.6x | 17.0x |
| Dividend Yield | 4.2% (Fully Franked) | 5.3% (Fully Franked) |
| 10-Year Growth Tendency | Low-volatility index matching (~9% p.a.) | High-volatility cyclical growth |
The Buffett-Style Breakdown
1. The Economic Moat (Competitive Advantage)
- ARG: No True Moat. As a traditional LIC, Argo owns a diversified slice of the ASX top 100. Its structural edge is low overheads (MER ~0.14%) and dividend smoothing, but it possesses no proprietary pricing power. Buffett would view this as a proxy for an index fund rather than a moat-protected castle. [1, 2]
- NHF: Narrow, Brand-Driven Moat. NIB operates as an insurance business (a sector Buffett favors via GEICO). It benefits from strong consumer brand recognition and regulatory tailwinds like the Australian Medicare Levy Surcharge, which enforces structural demand for private cover. [1]
2. Valuation (Price to Earnings)
- ARG: Overvalued (26.6x). A P/E this high for an entity holding slow-moving blue chips implies a premium price for low-growth assets. Buffett avoids paying premium earnings multiples unless it scales a compounding business. [1, 2]
- NHF: Favorable (17.0x). NIB trades closer to value territory. For a business producing solid returns on capital, a lower multiple reflects a safer entry price with a built-in margin of safety. [1]
3. Dividend & Dividend Growth
- ARG: The "Income Smoother". Argo pays a predictable 4.2% yield and recently increased its full-year dividend to 38.5 cents. Because it uses cash reserves to guarantee steady checks during market crashes, it operates exactly like the reliable income stream Buffett seeks for Berkshire’s operating cash.
4. Long-Term 10-Year Growth & Capital Allocation
- ARG: Passively Stable. Over 10 years, ARG has steadily tracked the ASX 200 accumulation index (~9.0% per annum total return). It achieves this by letting underlying holdings compound while retaining very little earnings to reinvest inside the business.
- NHF: Actively Reinvested. NIB relies on pricing power to counter healthcare inflation. It actively expands into travel and National Disability Insurance Scheme (NDIS) adjacencies. This strategy creates a classic compounder archetype: retaining a portion of earnings to reinvest at higher internal rates of return. [1, 2, 3]
The Verdict: Which Would Buffett Buy?
Buffett would likely view ASX:ARG as a vehicle for a hands-off investor looking to track the market securely. [1]
..................
More buffett analysis
nib holdings limited (ASX: NHF) demonstrates strong historical Return on Equity (ROE) that aligns well with standard defensive investment criteria. [1, 2]
However, its capital allocation strategy introduces a unique blend of high dividend payouts and targeted expansion that deviates slightly from Warren Buffett's traditional preference for heavy earnings retention. [1, 2]
1. Historical Return on Equity (ROE) Trends
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | 19.01% | 12.66% | 17.29% | 18.00% | 16.37% |
| Return on Invested Capital (ROIC) | 14.14% | 10.40% | 14.44% | 15.01% | 13.86% |
- The FY2023 Dip: The compression to 12.66% was primarily a cyclical correction coming out of pandemic-era anomalies, marked by a resumption of deferred medical claims and a catch-up in underwriting expenses. [1]
- The Post-2024 Recovery: ROE rebounded into the high teens, driven by organic policyholder growth and premium adjustments designed to combat claims inflation. [1]
2. Buffett Benchmark Comparison
Benchmark 1: Consistently High ROE (>15%)
Benchmark 2: The $1 Retained Earnings Test
- The Rule: A company must create at least $1 of market value for every $1 of earnings it retains instead of paying out to shareholders.
- NHF Performance: Mixed. NHF is a highly mature business operating in a regulated market. Instead of hoarding cash, it opts to distribute the vast majority of its earnings.
Benchmark 3: Capital Allocation & Reinvestment Moat
- The Rule: Buffett values managers who either deploy retained capital into high-return projects or return it to shareholders if no lucrative internal opportunities exist.
- NHF Performance: Passes via disciplined pivot. Because the core Australian health insurance market faces regulatory limits on pricing power, NHF treats its main unit as a cash cow.
- Strategic M&A: When it does retain capital or raise equity, it targets adjacent growth vectors. A key example is its ~$150 million institutional capital raise to fund its entry into the National Disability Insurance Scheme (NDIS) sector as a Plan Manager.
- This demonstrates an adaptive strategy: deploying capital into high-growth, fee-for-service digital marketplaces rather than over-allocating funds to low-yield capital reservoirs. [1, 2, 3]
Summary Checklist
...........................
No comments:
Post a Comment